Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study.

McGrath RT, Hocking SL, Priglinger M, Day S, Herkes GK, Krause M, Fulcher GR.

BMJ Open. 2016 Feb 24;6(2):e008203. doi: 10.1136/bmjopen-2015-008203.

2.

Brain histopathology in three cases of Susac's syndrome: implications for lesion pathogenesis and treatment.

Hardy TA, O'Brien B, Gerbis N, Barnett MH, Reddel SW, Brewer J, Herkes GK, Silberstein P, Garsia RJ, Watson JD, Gupta R, Parratt JD, Buckland ME.

J Neurol Neurosurg Psychiatry. 2015 May;86(5):582-4. doi: 10.1136/jnnp-2014-308240. No abstract available.

PMID:
25168394
3.

Sickle cell disease and posterior reversible leukoencephalopathy.

Geevasinga N, Cole C, Herkes GK, Barnett Y, Lin J, Needham M.

J Clin Neurosci. 2014 Aug;21(8):1329-32. doi: 10.1016/j.jocn.2013.10.028.

PMID:
24656986
4.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators..

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
5.

Angiostrongylus meningoencephalitis: survival from minimally conscious state to rehabilitation.

Blair NF, Orr CF, Delaney AP, Herkes GK.

Med J Aust. 2013 May 6;198(8):440-2. No abstract available.

PMID:
23641996
6.

Management of fingolimod-associated macular edema.

Chui J, Herkes GK, Chang A.

JAMA Ophthalmol. 2013 May;131(5):694-6. doi: 10.1001/jamaophthalmol.2013.47. No abstract available.

PMID:
23538612
7.

Weighty matters.

Herkes GK.

J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):711. doi: 10.1136/jnnp-2012-304586. No abstract available.

PMID:
23334630
8.

De novo mutations in ATP1A3 cause alternating hemiplegia of childhood.

Heinzen EL, Swoboda KJ, Hitomi Y, Gurrieri F, Nicole S, de Vries B, Tiziano FD, Fontaine B, Walley NM, Heavin S, Panagiotakaki E; European Alternating Hemiplegia of Childhood (AHC) Genetics Consortium.; Biobanca e Registro Clinico per l'Emiplegia Alternante (I.B.AHC) Consortium.; European Network for Research on Alternating Hemiplegia (ENRAH) for Small and Medium-sized Enterpriese (SMEs) Consortium., Fiori S, Abiusi E, Di Pietro L, Sweney MT, Newcomb TM, Viollet L, Huff C, Jorde LB, Reyna SP, Murphy KJ, Shianna KV, Gumbs CE, Little L, Silver K, Ptáček LJ, Haan J, Ferrari MD, Bye AM, Herkes GK, Whitelaw CM, Webb D, Lynch BJ, Uldall P, King MD, Scheffer IE, Neri G, Arzimanoglou A, van den Maagdenberg AM, Sisodiya SM, Mikati MA, Goldstein DB.

Nat Genet. 2012 Sep;44(9):1030-4. doi: 10.1038/ng.2358.

9.

The neurologic manifestations of the acute porphyrias.

Simon NG, Herkes GK.

J Clin Neurosci. 2011 Sep;18(9):1147-53. doi: 10.1016/j.jocn.2011.01.003. Review. Erratum in: J Clin Neurosci. 2012 Sep;19(9):e5.

PMID:
21724399
10.

Mitochondrial disease mimicking Charcot-Marie Tooth disease.

Needham M, Duley J, Hammond S, Herkes GK, Hirano M, Sue CM.

BMJ Case Rep. 2009;2009. pii: bcr06.2009.2001. doi: 10.1136/bcr.06.2009.2001.

11.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators., Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Erratum in: Lancet. 2008 Oct 18;372(9647):1384.

PMID:
18757085
12.

Is Sydenham's chorea an antiphospholipid syndrome?

Fung VS, Yiannikas C, Sue CM, Yiannikas J, Herkes GK, Crimmins DS.

J Clin Neurosci. 1998 Jan;5(1):115-8.

PMID:
18644307
13.

Transient visual obscurations and headache in aqueduct stenosis exacerbated by menstruation.

Fung VS, Herkes GK, Joffe R, Morgan MK.

J Clin Neurosci. 1998 Apr;5(2):245-6.

PMID:
18639024
14.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators., Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317.

15.

Mitochondrial disease mimicking Charcot-Marie Tooth disease.

Needham M, Duley J, Hammond S, Herkes GK, Hirano M, Sue CM.

J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):99-100. No abstract available.

16.

Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy.

Meagher LJ, McKay D, Herkes GK, Needham M.

J Clin Neurosci. 2006 Oct;13(8):857-9.

PMID:
16914315
17.

Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke.

Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, Stewart-Wynne EG, Rosen D, McNeil JJ, Bladin CF, Chambers BR, Herkes GK, Young D, Donnan GA.

Cerebrovasc Dis. 2005;20(1):12-7.

PMID:
15925877
18.

Stereochemistry in clinical medicine: a neurological perspective.

Cordato DJ, Mather LE, Herkes GK.

J Clin Neurosci. 2003 Nov;10(6):649-54. Review.

PMID:
14592610
19.

Barbiturates for acute neurological and neurosurgical emergencies--do they still have a role?

Cordato DJ, Herkes GK, Mather LE, Morgan MK.

J Clin Neurosci. 2003 May;10(3):283-8. Review.

PMID:
12763328
20.

Alterations in cerebral potentials evoked by rectal distension in irritable bowel syndrome.

Chan YK, Herkes GK, Badcock C, Evans PR, Bennett E, Kellow JE.

Am J Gastroenterol. 2001 Aug;96(8):2413-7.

PMID:
11513183

Supplemental Content

Loading ...
Support Center